Ishani Ganguli, MD, MPH, assistant professor of medicine at Harvard Medical School, physician at Brigham and Women’s Hospital, reacts to receiving the 2022 Seema S. Sonnad Emerging Leader in Managed Care Research Award.
Ishani Ganguli, MD, an assistant professor of medicine at Harvard Medical School, health services researcher, former journalist, and primary care physician in the Division of General Internal Medicine at Brigham and Women’s Hospital in Boston, received the 2022 Seema S. Sonnad Emerging Leader in Managed Care Research Award at the The American Journal of Managed Care® (AJMC®)'s 11th annual Patient-Centered Oncology Care this week. The award was established in honor of Seema S. Sonnad, PhD, a former associate editor of AJMC®, who passed away in May 2015.
Here, Ganguli discusses her research and how she got her start in her career.
Transcript
Can you discuss some of the research you've conducted related to managed care?
The work I do is broadly related to the value of ambulatory care. So I'm really interested in making outpatient care higher value for patients and to narrow the gap between what patients expect from the health care system and what we're actually able to provide.
There's a couple of different ways that I tend to look at this. One is through thinking about low-value care. In other words, services that clinicians order that have little to no benefit for patients with a potential for harm. Not just those services, but also the downstream consequences or cascades that can follow from those low-value services. Some of my work has been using claims data, national survey data, as well as electronic health record data to measure these cascades. Right now we're running a clinical trial to try to reduce them using a behavioral economic intervention. So that's a big part of my work.
Another piece that I'm really interested in is understanding how we pay for and deliver primary care and ambulatory care more generally, and thinking about the influence of new payment and delivery models on outcomes for patients, as well as for equity. So gender equity in medicine is another big area for me.
What made you interested in managed care research?
I came in to research in a bit of an unconventional way. When I was in high school and college, I wrote for the newspaper and I was a journalist. The summer after my junior year of college, I had this amazing opportunity to intern for ABC News Medical Unit, and I got really interested in medical journalism. I started out writing about basic sciences and medicine. I took 1 year off between college and med school to write full time and all my free time in med school, I wrote as a journalist. And as my clinical training progressed, I started to observe more and more the challenges in in how we deliver care to patients and how we pay for care. So I was writing increasingly about those challenges, essentially, was health services research. And so my entry point into the research came really from observing these challenges as a journalist, and then I had some opportunity during residency introduce me to try some research and then annually after my sort of my first research job after residency and a fellowship, rather, is when I really jumped into that work.
What was your reaction to receiving the 2022 Seema S. Sonnad Emerging Leader in Managed Care Research Award?
I am incredibly honored to receive this award. I want to thank my mentor, Dr Vinny Arora, who nominated me and is such a role model to me. And I never had the privilege of meeting Dr Sonnad. But from everything I've heard and read about her as a person, as a mentor, as a researcher, as a human being, she seems like such an amazing person. And so I'm just so honored to be to receive the support in her name, and I hope to be able to pay forward and and carry on the legacy that she was able to.
What other research are you a part of now or looking forward to working on?
One thing I've been thinking a lot about is how the decisions we make as clinicians impacts patients and how we don't always appreciate or think through all of the different impacts that we have those decisions have on patients. So one new area of research for me is thinking about something called the ambulatory care burden or contact days, which is this idea that every time we ask patients to come in for a lab test or for a visit or to be in the hospital for some time, it's both access to care but also a burden to patients often and can be challenging, especially if it's hard for a patient or their caregivers to come in to seek care. So some of my work has been thinking about ways of making that easier on patients, for example, through telemedicine, which of course has become much more common since the pandemic started, and other ways of trying to make care more efficient and easier on patients so that we, as a health care system, can sort of honor the tradeoffs and the additional burdens that patients have outside of spending their time with us.
The Push for Fair Pricing and Reform in Pharmacy Benefit Management
April 3rd 2025Amid growing legislative pressures and industry debates, pharmacy benefit managers (PBMs) are exploring new strategies to enhance transparency, reduce patient costs, and navigate the evolving healthcare landscape.
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Using AI-Driven Strategies to Optimize Specialty Drug Costs, Manage Polypharmacy
April 2nd 2025As health care costs continue to rise, artificial intelligence (AI)-driven solutions are emerging as a powerful tool for managing specialty drug spending and polypharmacy risks, as showcased in recent research presented at the Academy of Managed Care Pharmacy 2025 conference.
Read More
How Recent Federal Policy Changes Are Shaping Managed Care Pharmacy
April 2nd 2025Federal legislative and regulatory changes are reshaping pharmacy practice, with key challenges in government funding, pharmacy benefit manager reform, and health care policy shifts—topics explored by experts at the Academy of Managed Care Pharmacy's annual meeting.
Read More
The IRA’s Unintended Consequences for Drug Pricing and Coverage
April 2nd 2025The Inflation Reduction Act (IRA) may be restricting Medicare Part D formularies, increasing patient costs, and stifling pharmaceutical innovation, experts warned at the Academy of Managed Care Pharmacy 2025 annual meeting.
Read More